drug · antibody
mezagitamab
Phase 3updated 3mo agoby $TAK TAKEDA PHARMACEUTICAL CO LTD🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 10 investigational indications.
targets
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
all catalysts(0)
nothing on the calendar yet
Trials studying mezagitamab
- phase3A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
- phase3A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- phase3A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- phase1A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
- phase2A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 35m ago
Found something off?
comments(0)
5-min edit window · permanent after that